Literature DB >> 1554415

Isolation and partial characterization of murine O6-alkylguanine-DNA-alkyltransferase: comparative sequence and structural properties.

M Santibanez-Koref1, R H Elder, C Y Fan, L Cawkwell, J H McKie, K T Douglas, G P Margison, J A Rafferty.   

Abstract

A cDNA encoding murine O6-alkylguanine-DNA-alkyltransferase (ATase) has been sequenced after isolation from total liver RNA by the polymerase chain reaction using oligonucleotide primers derived from the rat ATase cDNA sequence. Functionally active murine ATase protein has been expressed in Escherichia coli at high levels (about 2% of total protein) and purified to apparent homogeneity (molecular mass 26 kDa). In liquid hybridization experiments, anti-human ATase polyclonal antibodies inhibited human but not rat or mouse ATase, whereas anti-rat polyclonal antibodies inhibited rat and mouse but not human ATase. Both antibodies detected all mammalian ATases tested by western analysis so far. These results indicate some common epitopes and at least one unique human epitope. We compared the amino-acid sequence of the murine ATase with those of other mammalian and bacterial ATases. The proteins of this family all have a large domain (approximately 70 amino acids) of highly conserved residues flanking the sequence PCHRV, which contains the alkyl-accepting cysteine residue of the active site. No evidence was found in the sequences for helix-turn-helix, leucine-zipper, or zinc-finger motifs for DNA recognition and binding. Nuclear localization signals (basic-residue-rich regions) could not be uniquely identified in the mammalian members of the family. Outside of the conserved PCHRV region, there were major differences between prokaryotic and eukaryotic proteins at the primary structure level: there was a series of proline-rich motifs, but these also varied between sequences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554415     DOI: 10.1002/mc.2940050212

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

Review 1.  Self-destruction and tolerance in resistance of mammalian cells to alkylation damage.

Authors:  P Karran; M Bignami
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

2.  Binding and repair of O6-ethylguanine in double-stranded oligodeoxynucleotides by recombinant human O6-alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context.

Authors:  K Bender; M Federwisch; U Loggen; P Nehls; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

3.  Specificities of human, rat and E. coli O6-methylguanine-DNA methyltransferases towards the repair of O6-methyl and O6-ethylguanine in DNA.

Authors:  L K Liem; A Lim; B F Li
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

4.  Thermostable archaeal O6-alkylguanine-DNA alkyltransferases.

Authors:  M Skorvaga; N D Raven; G P Margison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

5.  Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine.

Authors:  R H Elder; G P Margison; J A Rafferty
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

6.  Expression of the E.coli ada gene in S.cerevisiae provides cellular resistance to N-methyl-N'-nitro-N-nitrosoguanidine in rad6 but not in rad52 mutants.

Authors:  J Brozmanová; V Vlcková; M Chovanec; L Cernáková; M Skorvaga; G P Margison
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

7.  C-terminally truncated human O6-alkylguanine-DNA alkyltransferase retains activity.

Authors:  R H Elder; J Tumelty; K T Douglas; G P Margison; J A Rafferty
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma.

Authors:  S M Lee; J A Rafferty; R H Elder; C Y Fan; M Bromley; M Harris; N Thatcher; P M Potter; H J Altermatt; T Perinat-Frey
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

9.  Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.

Authors:  S M Lee; D Crowther; J H Scarffe; M Dougal; R H Elder; J A Rafferty; G P Margison
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.